G. Retalis

Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients.

V. Georgoulias, A. Giatromanolaki, M. Koukourakis, 2002, International journal of radiation oncology, biology, physics.

Concurrent administration of Docetaxel and Stealth® liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection

K. Romanidis, M. Koukourakis, G. Kyrgias, 2002, British Journal of Cancer.

Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer

V. Georgoulias, A. Giatromanolaki, M. Koukourakis, 2000, Medical oncology.

A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma

R. Crevoisier, J. Bourhis, V. Georgoulias, 2001 .

Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study.

V. Georgoulias, A. Giatromanolaki, M. Koukourakis, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer.

A. Giatromanolaki, M. Koukourakis, S. Koukouraki, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oral administration of recombinant human granulocyte macrophage colony-stimulating factor in the management of radiotherapy-induced esophagitis.

A. Giatromanolaki, C. Flordellis, M. Koukourakis, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Surgical adjuvant therapy of rectal carcinoma: a controlled evaluation of leucovorin, 5-fluorouracil and radiation therapy with or without interferon-alpha2b.

C. Dardoufas, G. Androulakis, G. Peros, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Combined treatment with low-dose interferon plus vinblastine is associated with less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma.

P. Kosmidis, D. Skarlos, N. Tsavaris, 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Interferon-a2b Reduces Neo-Microvascular Density in the ‘Normal’ Urothelium Adjacent to the Tumor after Transurethral Resection of Superficial Bladder Carcinoma

V. Gorgoulis, A. Giannopoulos, A. Athanasiou, 2003, Oncology Research and Treatment.

Adjuvant systemic therapy protocol for Dukes' B2 and C resectable colon carcinoma.

G. Androulakis, V. Georgoulias, G. Peros, 2002, Tumori.

177 Subcutaneous amifostine during fractionated radiotherapy for lung, pelvic and head and neck cancer: A randomized phase II study

V. Georgoulias, A. Giatromanolaki, M. Koukourakis, 1999 .